Mad in America

JANUARY 4, 2025

In 2006, the American Journal of Psychiatry (AJP) published four reports on STAR*D outcomes. Without these imaginary remissions, the reported remission rate in the November 2006 paper would have been around 50%. Nearly 70% of real-world patients could expect to become symptom free with this use of antidepressants.

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

OCTOBER 10, 2023

The number of pharmaceutical products in the home today is unprecedented—and drugs, both legal and illegal, continue to be the leading cause of child poisoning. Rebecca started seeing a psychiatrist at the age of two and was diagnosed with attention-deficit hyperactivity disorder and pediatric bipolar disorder.

Manufacturing 130

Manufacturing Pharmaceuticals Aging and mental health Nonprofits 130

Mad in America

OCTOBER 21, 2023

One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolar disorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.

Technology 137

Technology Genetics and mental health Pharmaceuticals Sleep and mental health 137